CAMLINFINEBSECamlin Fine Sciences LtdMinimalNeutral
Announced Wed, 27 May · 12:52 IST

Newspaper Publication - Audited Financial Results for the quarter and year ended 31.03.2026

CAMLINFINE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+0.8%1-day move
₹121.50
prior close
₹128.69
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.0+0.0+0.2+0.2+0.8-2.9-2.1-3.6-1.2+4.7+12.8+6.9+5.2
Up moveDown movePending
AI summary

Camlin Fine Sciences published its audited Q4 and full-year FY26 financial results in newspapers (Financial Express and Loksatta) on May 27, 2026, as required under SEBI Listing Regulations. Standalone performance was poor with a net loss of ₹564.95 lakh in Q4 and ₹3,296.62 lakh for the full year, despite revenue of ₹18,352 lakh in Q4 and ₹83,792 lakh for the year. However, the consolidated picture was significantly better, showing net profit of ₹8,627.73 lakh for Q4 and ₹2,354.32 lakh for FY26 on consolidated revenue of ₹1,72,331 lakh, indicating strong contribution from subsidiaries. Consolidated EPS stood at ₹1.46 per share (basic, not annualised).

Likely market impact

The wide gap between standalone loss and consolidated profit is notable — the standalone entity is loss-making while group subsidiaries are driving profitability. Investors should focus on consolidated numbers for a true picture of performance.